市場調査レポート
商品コード
1073228

家庭用睡眠時無呼吸症候群検査デバイスの世界市場 (2022-2030年):市場予測 (タイプ2・3・4別)・地域的展望・用途の潜在性・市場シェア

Home Sleep Apnea Testing Devices Market Size By Test Type (Type 2, Type 3, Type 4), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 95 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
家庭用睡眠時無呼吸症候群検査デバイスの世界市場 (2022-2030年):市場予測 (タイプ2・3・4別)・地域的展望・用途の潜在性・市場シェア
出版日: 2022年08月16日
発行: Global Market Insights Inc.
ページ情報: 英文 95 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家庭用睡眠時無呼吸症候群検査デバイスの市場は、睡眠モニタリング手法や検査デバイスの採用が進んでいることから、2028年にかけて大きく成長すると予測されています。

また、先端技術に関するR&D費の増加も予測期間を通じて市場の成長を促進する可能性があります。

検査タイプ別で見ると、タイプ4の部門が2021年に約24%の市場シェアを占め、複数の睡眠障害の検査における利点や、認知度の上昇から、堅調な成長を示しています。また、地域別では、ラテンアメリカ地域が2021年に9,100万米ドル超を示し、予測期間中も高い成長を示す可能性が高いと考えられています。この成長は、同地域における高齢者人口の増加と、睡眠時無呼吸症候群やその他の睡眠障害に関する認知度の向上に起因しています。

当レポートでは、世界の家庭用睡眠時無呼吸症候群検査デバイスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制・償還環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 家庭用睡眠時無呼吸症候群検査デバイス産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性の分析
  • COVID-19:影響分析
  • 規制状況
  • 償還シナリオ
  • 技術情勢
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 家庭用睡眠時無呼吸症候群検査デバイス市場:検査タイプ別

  • 主要動向
  • タイプ2
  • タイプ3
  • タイプ4

第5章 家庭用睡眠時無呼吸症候群検査デバイス市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

  • 競合ダッシュボード
  • Compumedics Limited
  • Cadwell Laboratories Inc.
  • CleveMed
  • Contec Medical Systems
  • Itamar Medical Inc.
  • Koninklijke Philips N.V.
  • Natus Medical Inc.
  • Neurosoft
  • NeuroVirtual/SleepVirtual
  • Nihon Kohden Corporation
  • Nox Medical
  • Resmed
  • SleepMed
  • SOMNOmedics GmbH
図表

DATA TABLES

  • TABLE 1 Global home sleep apnea testing devices market, 2017 - 2021 (USD Million)
  • TABLE 2 Global home sleep apnea testing devices market, 2022 - 2030 (USD Million)
  • TABLE 3 Global home sleep apnea testing devices market, by test type, 2017 - 2021 (USD Million)
  • TABLE 4 Global home sleep apnea testing devices market, by test type, 2022 - 2030 (USD Million)
  • TABLE 5 Global home sleep apnea testing devices market, by region, 2017 - 2021 (USD Million)
  • TABLE 6 Global home sleep apnea testing devices market, by region, 2022 - 2030 (USD Million)
  • TABLE 7 Industry impact forces
  • TABLE 8 Type 2 market, by region, 2017 - 2021, (USD Million)
  • TABLE 9 Type 2 Market, by region, 2022 - 2030, (USD Million)
  • TABLE 10 Type 3 market, by region, 2017 - 2021, (USD Million)
  • TABLE 11 Type 3 market, by region, 2022 - 2030, (USD Million)
  • TABLE 12 Type 4 market, by region, 2017 - 2021, (USD Million)
  • TABLE 13 Type 4 market, by region, 2022 - 2030, (USD Million)
  • TABLE 14 North America home sleep apnea testing devices market, by country, 2017-2021, (USD Million)
  • TABLE 15 North America home sleep apnea testing devices market, by country, 2022-2030, (USD Million)
  • TABLE 16 North America home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 17 North America home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 18 U.S. home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 19 U.S. home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 20 Canada home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 21 Canada home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 22 Europe home sleep apnea testing devices market, by country, 2017-2021, (USD Million)
  • TABLE 23 Europe home sleep apnea testing devices market, by country, 2022-2030, (USD Million)
  • TABLE 24 Europe home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 25 Europe home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 26 Germany home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 27 Germany home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 28 UK home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 29 UK home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 30 France home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 31 France home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 32 Spain home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 33 Spain home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 34 Italy home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 35 Italy home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 36 Asia Pacific home sleep apnea testing devices market, by country, 2017-2021, (USD Million)
  • TABLE 37 Asia Pacific home sleep apnea testing devices market, by country, 2022-2030, (USD Million)
  • TABLE 38 Asia Pacific home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 39 Asia Pacific home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 40 China home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 41 China home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 42 Japan home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 43 Japan home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 44 India home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 45 India home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 46 Australia home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 47 Australia home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 48 South Korea home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 49 South Korea home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 50 Latin America home sleep apnea testing devices market, by country, 2017-2021, (USD Million)
  • TABLE 51 Latin America home sleep apnea testing devices market, by country, 2022-2030, (USD Million)
  • TABLE 52 Latin America home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 53 Latin America home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 54 Brazil home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 55 Brazil home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 56 Mexico home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 57 Mexico home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 58 Argentina home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 59 Argentina home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 60 MEA home sleep apnea testing devices market, by country, 2017-2021, (USD Million)
  • TABLE 61 MEA home sleep apnea testing devices market, by country, 2022-2030, (USD Million)
  • TABLE 62 MEA home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 63 MEA home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 64 South Africa home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 65 South Africa home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 66 Saudi Arabia home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 67 Saudi Arabia home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)
  • TABLE 68 UAE home sleep apnea testing devices market, by test type, 2017-2021, (USD Million)
  • TABLE 69 UAE home sleep apnea testing devices market, by test type, 2022-2030, (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Home sleep apnea testing devices market industry 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global home sleep apnea testing devices, by region, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by test type
  • FIG. 7 Porter's analysis
  • FIG. 8 Company matrix analysis, 2021
  • FIG. 9 PESTEL analysis
  • FIG. 10Key segment trends, by test type
  • FIG. 11Key regional trends
  • FIG. 12Strategy dashboard, 2021
目次
Product Code: 4439

The home sleep apnea testing devices market size is projected to grow substantially by 2030 driven by escalating geriatric population worldwide. Sleep-related breathing disorders like obstructive and central sleep apnea are more common among the elderly. Alcohol consumption, obesity, and smoking are also some of the contributors to sleep apnea. Elderly patients suffering from sleep apnea are also more prone to other medical disorders such as myocardial infarction, congestive heart failure, and stroke.

According to the World Health Organization (WHO), the global geriatric population is expected to double by 2050. Additionally, the elderly population aged above 60 years is expected to witness threefold growth by 2050, reaching about 1.3 billion.

Several industry players are foraying into strategic partnerships and expansions to ramp up the innovation of sleep apnea testing and treatment. In August 2022, ResMed acquired German digital solutions provider Mementor to expand its overall sleep portfolio in Germany with a digital solution for insomnia. ResMed also unveiled its new technology R&D center in Sandyford, Dublin alongside plans to scale up the performance of its Ireland-based unit.

Meanwhile, various new entities in the home sleep apnea testing devices industry are introducing groundbreaking technologies. For instance, in May 2022, Sunrise, a Belgian sleep tech company, launched a lightweight and user-friendly at-home sleep test.

In November 2021, Acurable, a UK-based medical device company, received FDA approval for its AcuPebble SA100, a compact wearable device that enables automated remote home testing of obstructive sleep apnea.

The global home sleep apnea testing devices industry is bifurcated into test type and region.

With respect to test type, the industry is fragmented into type 2, type 3, and type 4. In 2021, the type 4 segment held more than 24% of the market share and is expected to reach over USD 828 million by 2030. Type 4 home sleep apnea testing devices ensure precise disease diagnosis and help assess the treatment efficacy.

In the regional landscape, the Asia Pacific home sleep apnea testing devices market size is estimated to value more than USD 872 million by 2030. APAC is home to a massive geriatric population base and represents a considerable share of sleep apnea and other sleep disorders. Rapid privatization of the healthcare sector and medical tourism will favor businesses operating in the home sleep apnea testing devices space in the region.

Developing economies of APAC are boosting health insurance penetration along with advancements in remote and at-home healthcare. In 2021, the World Bank granted $40 million worth of funding to the Meghalaya Health Systems Strengthening Project in India. The project is established to expand health insurance coverage in the state, provide better quality health services and facilitate access to diagnostics and medicines.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Home sleep apnea testing devices industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Test type trends
    • 2.1.3 Regional trends

Chapter 3 Home Sleep Apnea Testing Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of sleep apnea and related co-morbidities
      • 3.3.1.2 Increasing awareness regarding home sleep apnea tests
      • 3.3.1.3 Increasing aging population
      • 3.3.1.4 Product innovation strategy adopted by key industry players
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Clinical consequences and economic impact of sleep apnea and related sleep disorders
      • 3.3.2.2 Stringent regulations
  • 3.4 Growth potential analysis
    • 3.4.1 By test type
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Technological landscape
  • 3.9 Porter's analysis
  • 3.10 Competitive landscape, 2021
    • 3.10.1 Competitive matrix analysis, 2021
  • 3.11 PESTEL analysis

Chapter 4 Home Sleep Apnea Testing Devices Market, By Test Type

  • 4.1 Key segment trends
  • 4.2 Type 2
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Type 3
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Type 4
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Home Sleep Apnea Testing Devices Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.2.2 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market size, by test type, 2017 - 2030 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.3.2 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.3.5 France
      • 5.3.5.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.3.6 Spain
      • 5.3.6.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.3.7 Italy
      • 5.3.7.1 Market size, by test type, 2017 - 2030 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.4.2 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.4.4 Japan
      • 5.4.4.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.4.5 India
      • 5.4.5.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.4.6 Australia
      • 5.4.6.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.4.7 South Korea
      • 5.4.7.1 Market size, by test type, 2017 - 2030 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.5.2 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.5.5 Argentina
      • 5.5.5.1 Market size, by test type, 2017 - 2030 (USD Million)
  • 5.6 Middle East and Africa
    • 5.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.6.2 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.6.3 South Africa
      • 5.6.3.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.6.4 Saudi Arabia
      • 5.6.4.1 Market size, by test type, 2017 - 2030 (USD Million)
    • 5.6.5 UAE
      • 5.6.5.1 Market size, by test type, 2017 - 2030 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Competitive dashboard, 2021
  • 6.2 Compumedics Limited
    • 6.2.1 Business overview
    • 6.2.2 Financial data
    • 6.2.3 Product landscape
    • 6.2.4 Strategic outlook
    • 6.2.5 SWOT analysis
  • 6.3 Cadwell Laboratories Inc.
    • 6.3.1 Business overview
    • 6.3.2 Financial data
    • 6.3.3 Product landscape
    • 6.3.4 Strategic outlook
    • 6.3.5 SWOT analysis
  • 6.4 CleveMed
    • 6.4.1 Business overview
    • 6.4.2 Financial data
    • 6.4.3 Product landscape
    • 6.4.4 Strategic outlook
    • 6.4.5 SWOT analysis
  • 6.5 Contec Medical Systems
    • 6.5.1 Business overview
    • 6.5.2 Financial data
    • 6.5.3 Product landscape
    • 6.5.4 Strategic outlook
    • 6.5.5 SWOT analysis
  • 6.6 Itamar Medical Inc.
    • 6.6.1 Business overview
    • 6.6.2 Financial data
    • 6.6.3 Product landscape
    • 6.6.4 Strategic outlook
    • 6.6.5 SWOT analysis
  • 6.7 Koninklijke Philips N.V.
    • 6.7.1 Business overview
    • 6.7.2 Financial data
    • 6.7.3 Product landscape
    • 6.7.4 Strategic outlook
    • 6.7.5 SWOT analysis
  • 6.8 Natus Medical Inc.
    • 6.8.1 Business overview
    • 6.8.2 Financial data
    • 6.8.3 Product landscape
    • 6.8.4 Strategic outlook
    • 6.8.5 SWOT analysis
  • 6.9 Neurosoft
    • 6.9.1 Business overview
    • 6.9.2 Financial data
    • 6.9.3 Product landscape
    • 6.9.4 Strategic outlook
    • 6.9.5 SWOT analysis
  • 6.10 NeuroVirtual/SleepVirtual
    • 6.10.1 Business overview
    • 6.10.2 Financial data
    • 6.10.3 Product landscape
    • 6.10.4 Strategic outlook
    • 6.10.5 SWOT analysis
  • 6.11 Nihon Kohden Corporation
    • 6.11.1 Business overview
    • 6.11.2 Financial data
    • 6.11.3 Product landscape
    • 6.11.4 Strategic outlook
    • 6.11.5 SWOT analysis
  • 6.12 Nox Medical
    • 6.12.1 Business overview
    • 6.12.2 Financial data
    • 6.12.3 Product landscape
    • 6.12.4 Strategic outlook
    • 6.12.5 SWOT analysis
  • 6.13 Resmed
    • 6.13.1 Business overview
    • 6.13.2 Financial data
    • 6.13.3 Product landscape
    • 6.13.4 Strategic outlook
    • 6.13.5 SWOT analysis
  • 6.14 SleepMed
    • 6.14.1 Business overview
    • 6.14.2 Financial data
    • 6.14.3 Product landscape
    • 6.14.4 Strategic outlook
    • 6.14.5 SWOT analysis
  • 6.15 SOMNOmedics GmbH
    • 6.15.1 Business overview
    • 6.15.2 Financial data
    • 6.15.3 Product landscape
    • 6.15.4 Strategic outlook
    • 6.15.5 SWOT analysis